 BEIJING, Sept. 10, 2021 PRNewswire -- Concord Medical Services Holdings Limited Concord Medical or the Company NYSE: CCM, a healthcare provider specialized in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that Shanghai Concord Cancer Center SCCC, or the planned hospital, a business subsidiary of an important operating platform of the Company, Meizhong Jiahe Medical Science Technology Development Group Co., Ltd. 